255 related articles for article (PubMed ID: 21190047)
1. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
Walter U
J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
[TBL] [Abstract][Full Text] [Related]
5. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
6. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
7. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
[TBL] [Abstract][Full Text] [Related]
8. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
9. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
10. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
12. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
[TBL] [Abstract][Full Text] [Related]
13. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
[TBL] [Abstract][Full Text] [Related]
14. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
[TBL] [Abstract][Full Text] [Related]
15. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
16. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
[TBL] [Abstract][Full Text] [Related]
17. Feature analysis for Parkinson's disease detection based on transcranial sonography image.
Chen L; Hagenah J; Mertins A
Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):272-9. PubMed ID: 23286140
[TBL] [Abstract][Full Text] [Related]
18. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
[TBL] [Abstract][Full Text] [Related]
19. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
[TBL] [Abstract][Full Text] [Related]
20. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
Walter U
Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]